In more than half of all heart attacks, there were no prior symptoms. Yet we almost exclusively screen for heart disease only when someone has symptoms. The result: Germany leads the world in cardiac catheterizations—and at the same time ranks last in Europe in terms of life expectancy. AI can change that. The Cardio Explorer® analyzes simple lab values and calculates an individual’s risk of CHD—with over 95% accuracy, effortlessly, and fully automated within the hospital information system. Many thanks to Prof. Andrew Remppis for his clear perspective on a long-overdue topic.
